LeMaitre Vascular, Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 10 of 11 compared factors.
Size & Scale
| LMAT | RMD | |
|---|---|---|
| Market Cap | $1.86 billion | $30.74 billion |
| Revenue (TTM) | $262.43 million | $5.54 billion |
| Net Income (TTM) | $65.67 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| LMAT | RMD | |
|---|---|---|
| P/E Ratio | 28.58 | 20.44 |
| Price / Book | 4.43 | 4.74 |
| Price / Sales | 7.10 | 5.55 |
RMD leads on 2 of 3 valuation factors.
Profitability
| LMAT | RMD | |
|---|---|---|
| Net Margin | 25.02% | 27.44% |
| Return on Equity | 15.62% | 23.41% |
RMD leads on 2 of 2 profitability factors.
Dividend
| LMAT | RMD | |
|---|---|---|
| Dividend Yield | 1.23% | 1.25% |
| Payout Ratio | 35.09 | 25.46 |
RMD leads on 2 of 2 dividend factors.
Risk & Sentiment
| LMAT | RMD | |
|---|---|---|
| Short Interest | 4.36% | 4.02% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: LMAT overview, LMAT financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.